Trends in drug delivery through tissue barriers containing tight junctions

References

• Kinne RK. Endothelial and epithelial cells: general principles of selective vectorial transport. Int J Microcirc Clin Exp 1997; 17:223 - 30; http://dx.doi.org/10.1159/000179234; PMID: 9370122
   PubMedGoogle Scholar
• Abbott NJ. Dynamics of CNS barriers: evolution, differentiation, and modulation. Cell Mol Neurobiol 2005; 25:5 - 23; http://dx.doi.org/10.1007/s10571-004-1374-y; PMID: 15962506
   PubMed Web of Science ®Google Scholar
• Brandner JM, Kief S, Wladykowski E, Houdek P, Moll I. Tight junction proteins in the skin. Skin Pharmacol Physiol 2006; 19:71 - 7; http://dx.doi.org/10.1159/000091973; PMID: 16685145
   PubMed Web of Science ®Google Scholar
• Camilleri M, Madsen K, Spiller R, Greenwood-Van Meerveld B, Verne GN. Intestinal barrier function in health and gastrointestinal disease. Neurogastroenterol Motil 2012; 24:503 - 12; http://dx.doi.org/10.1111/j.1365-2982.2012.01921.x; PMID: 22583600
   PubMed Web of Science ®Google Scholar
• Krause G, Winkler L, Mueller SL, Haseloff RF, Piontek J, Blasig IE. Structure and function of claudins. Biochim Biophys Acta 2008; 1778:631 - 45; http://dx.doi.org/10.1016/j.bbamem.2007.10.018; PMID: 18036336
   PubMed Web of Science ®Google Scholar
• Raleigh DR, Marchiando AM, Zhang Y, Shen L, Sasaki H, Wang Y, et al. Tight junction-associated MARVEL proteins marveld3, tricellulin, and occludin have distinct but overlapping functions. Mol Biol Cell 2010; 21:1200 - 13; http://dx.doi.org/10.1091/mbc.E09-08-0734; PMID: 20164257
   PubMed Web of Science ®Google Scholar
• Steed E, Rodrigues NT, Balda MS, Matter K. Identification of MarvelD3 as a tight junction-associated transmembrane protein of the occludin family. BMC Cell Biol 2009; 10:95; http://dx.doi.org/10.1186/1471-2121-10-95; PMID: 20028514
   PubMed Web of Science ®Google Scholar
• Furuse M. Knockout animals and natural mutations as experimental and diagnostic tool for studying tight junction functions in vivo. Biochim Biophys Acta 2009; 1788:813 - 9; http://dx.doi.org/10.1016/j.bbamem.2008.07.017; PMID: 18706387
   PubMed Web of Science ®Google Scholar
• Furuse M. Molecular basis of the core structure of tight junctions. Cold Spring Harb Perspect Biol 2010; 2:a002907; http://dx.doi.org/10.1101/cshperspect.a002907; PMID: 20182608
   PubMed Web of Science ®Google Scholar
• Furuse M, Hirase T, Itoh M, Nagafuchi A, Yonemura S, Tsukita S, et al. Occludin: a novel integral membrane protein localizing at tight junctions. J Cell Biol 1993; 123:1777 - 88; http://dx.doi.org/10.1083/jcb.123.6.1777; PMID: 8276896
   PubMed Web of Science ®Google Scholar
• Dörfel MJ, Huber O. Modulation of tight junction structure and function by kinases and phosphatases targeting occludin. J Biomed Biotechnol 2012; 2012:807356; http://dx.doi.org/10.1155/2012/807356; PMID: 22315516
   PubMed Web of Science ®Google Scholar
• Blasig IE, Bellmann C, Cording J, Del Vecchio G, Zwanziger D, Huber O, et al. Occludin protein family: oxidative stress and reducing conditions. Antioxid Redox Signal 2011; 15:1195 - 219; http://dx.doi.org/10.1089/ars.2010.3542; PMID: 21235353
   PubMed Web of Science ®Google Scholar
• Ikenouchi J, Furuse M, Furuse K, Sasaki H, Tsukita S, Tsukita S. Tricellulin constitutes a novel barrier at tricellular contacts of epithelial cells. J Cell Biol 2005; 171:939 - 45; http://dx.doi.org/10.1083/jcb.200510043; PMID: 16365161
   PubMed Web of Science ®Google Scholar
• Mariano C, Sasaki H, Brites D, Brito MA. A look at tricellulin and its role in tight junction formation and maintenance. Eur J Cell Biol 2011; 90:787 - 96; http://dx.doi.org/10.1016/j.ejcb.2011.06.005; PMID: 21868126
   PubMed Web of Science ®Google Scholar
• Furuse M, Fujita K, Hiiragi T, Fujimoto K, Tsukita S. Claudin-1 and -2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin. J Cell Biol 1998; 141:1539 - 50; http://dx.doi.org/10.1083/jcb.141.7.1539; PMID: 9647647
   PubMed Web of Science ®Google Scholar
• Mineta K, Yamamoto Y, Yamazaki Y, Tanaka H, Tada Y, Saito K, et al. Predicted expansion of the claudin multigene family. FEBS Lett 2011; 585:606 - 12; http://dx.doi.org/10.1016/j.febslet.2011.01.028; PMID: 21276448
   PubMed Web of Science ®Google Scholar
• Umeda K, Ikenouchi J, Katahira-Tayama S, Furuse K, Sasaki H, Nakayama M, et al. ZO-1 and ZO-2 independently determine where claudins are polymerized in tight-junction strand formation. Cell 2006; 126:741 - 54; http://dx.doi.org/10.1016/j.cell.2006.06.043; PMID: 16923393
   PubMed Web of Science ®Google Scholar
• Piontek J, Winkler L, Wolburg H, Müller SL, Zuleger N, Piehl C, et al. Formation of tight junction: determinants of homophilic interaction between classic claudins. FASEB J 2008; a 22:146 - 58; http://dx.doi.org/10.1096/fj.07-8319com; PMID: 17761522
   PubMed Web of Science ®Google Scholar
• Piontek J, Fritzsche S, Cording J, Richter S, Hartwig J, Walter M, et al. Elucidating the principles of the molecular organization of heteropolymeric tight junction strands. Cell Mol Life Sci 2011; 68:3903 - 18; http://dx.doi.org/10.1007/s00018-011-0680-z; PMID: 21533891
   PubMed Web of Science ®Google Scholar
• Cording J, Berg J, Kading N, Bellmann C, Tscheik C, Westphal JK, et al. Tight junctions: Claudins regulate the interactions between occludin, tricellulin and marvelD3, which, inversely, modulate claudin oligomerization. J Cell Sci 2012; 126:554 - 64; http://dx.doi.org/10.1242/jcs.114306; PMID: 23203797
   PubMed Web of Science ®Google Scholar
• Furuse M, Sasaki H, Tsukita S. Manner of interaction of heterogeneous claudin species within and between tight junction strands. J Cell Biol 1999; 147:891 - 903; http://dx.doi.org/10.1083/jcb.147.4.891; PMID: 10562289
   PubMed Web of Science ®Google Scholar
• Amasheh S, Meiri N, Gitter AH, Schöneberg T, Mankertz J, Schulzke JD, et al. Claudin-2 expression induces cation-selective channels in tight junctions of epithelial cells. J Cell Sci 2002; 115:4969 - 76; http://dx.doi.org/10.1242/jcs.00165; PMID: 12432083
   PubMed Web of Science ®Google Scholar
• Nitta T, Hata M, Gotoh S, Seo Y, Sasaki H, Hashimoto N, et al. Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J Cell Biol 2003; 161:653 - 60; http://dx.doi.org/10.1083/jcb.200302070; PMID: 12743111
   PubMed Web of Science ®Google Scholar
• Wen H, Watry DD, Marcondes MC, Fox HS. Selective decrease in paracellular conductance of tight junctions: role of the first extracellular domain of claudin-5. Mol Cell Biol 2004; 24:8408 - 17; http://dx.doi.org/10.1128/MCB.24.19.8408-8417.2004; PMID: 15367662
   PubMed Web of Science ®Google Scholar
• Colegio OR, Van Itallie CM, McCrea HJ, Rahner C, Anderson JM. Claudins create charge-selective channels in the paracellular pathway between epithelial cells. Am J Physiol Cell Physiol 2002; 283:C142 - 7; PMID: 12055082
   PubMed Web of Science ®Google Scholar
• Piehl C, Piontek J, Cording J, Wolburg H, Blasig IE. Participation of the second extracellular loop of claudin-5 in paracellular tightening against ions, small and large molecules. Cell Mol Life Sci 2010; 67:2131 - 40; http://dx.doi.org/10.1007/s00018-010-0332-8; PMID: 20333434
   PubMed Web of Science ®Google Scholar
• Veshnyakova A, Krug SM, Mueller SL, Piontek J, Protze J, Fromm M, et al. Determinants contributing to claudin ion channel formation. Ann N Y Acad Sci 2012; a 1257:45 - 53; http://dx.doi.org/10.1111/j.1749-6632.2012.06566.x; PMID: 22671588
   PubMed Web of Science ®Google Scholar
• Blasig IE, Winkler L, Lassowski B, Mueller SL, Zuleger N, Krause E, et al. On the self-association potential of transmembrane tight junction proteins. Cell Mol Life Sci 2006; 63:505 - 14; http://dx.doi.org/10.1007/s00018-005-5472-x; PMID: 16456617
   PubMed Web of Science ®Google Scholar
• Pardridge WM. The blood-brain barrier: bottleneck in brain drug development. NeuroRx 2005; 2:3 - 14; http://dx.doi.org/10.1602/neurorx.2.1.3; PMID: 15717053
   PubMedGoogle Scholar
• Pardridge WM. Brain Drug Targeting: The Future of Brain Drug Development. Cambridge, U.K.: 2001.
   Google Scholar
• Brandsch M, Knütter I, Bosse-Doenecke E. Pharmaceutical and pharmacological importance of peptide transporters. J Pharm Pharmacol 2008; 60:543 - 85; http://dx.doi.org/10.1211/jpp.60.5.0002; PMID: 18416933
   PubMed Web of Science ®Google Scholar
• Petrus AK, Allis DG, Smith RP, Fairchild TJ, Doyle RP. Exploring the implications of vitamin B12 conjugation to insulin on insulin receptor binding. ChemMedChem 2009; 4:421 - 6; http://dx.doi.org/10.1002/cmdc.200800346; PMID: 19101970
   PubMed Web of Science ®Google Scholar
• Hussain A, Arnold JJ, Khan MA, Ahsan F. Absorption enhancers in pulmonary protein delivery. J Control Release 2004; 94:15 - 24; http://dx.doi.org/10.1016/j.jconrel.2003.10.001; PMID: 14684268
   PubMed Web of Science ®Google Scholar
• Lindmark T, Kimura Y, Artursson P. Absorption enhancement through intracellular regulation of tight junction permeability by medium chain fatty acids in Caco-2 cells. J Pharmacol Exp Ther 1998; 284:362 - 9; PMID: 9435199
   PubMed Web of Science ®Google Scholar
• Walsh EG, Adamczyk BE, Chalasani KB, Maher S, O’Toole EB, Fox JS, et al. Oral delivery of macromolecules: rationale underpinning Gastrointestinal Permeation Enhancement Technology (GIPET). Ther Deliv 2011; 2:1595 - 610; http://dx.doi.org/10.4155/tde.11.132; PMID: 22833984
   PubMedGoogle Scholar
• Nusrat A, Brown GT, Tom J, Drake A, Bui TT, Quan C, et al. Multiple protein interactions involving proposed extracellular loop domains of the tight junction protein occludin. Mol Biol Cell 2005; 16:1725 - 34; http://dx.doi.org/10.1091/mbc.E04-06-0465; PMID: 15659655
   PubMed Web of Science ®Google Scholar
• Campbell M, Nguyen AT, Kiang AS, Tam LC, Gobbo OL, Kerskens C, et al. An experimental platform for systemic drug delivery to the retina. Proc Natl Acad Sci U S A 2009; 106:17817 - 22; http://dx.doi.org/10.1073/pnas.0908561106; PMID: 19822744
   PubMed Web of Science ®Google Scholar
• Sousa SM, Bramante CM, Taga EM. Biocompatibility of EDTA, EGTA and citric acid. Braz Dent J 2005; 16:3 - 8; http://dx.doi.org/10.1590/S0103-64402005000100001; PMID: 16113926
   PubMedGoogle Scholar
• Kanner AA, Marchi N, Fazio V, Mayberg MR, Koltz MT, Siomin V, et al. Serum S100beta: a noninvasive marker of blood-brain barrier function and brain lesions. Cancer 2003; 97:2806 - 13; http://dx.doi.org/10.1002/cncr.11409; PMID: 12767094
   PubMed Web of Science ®Google Scholar
• Hackel D, Krug SM, Sauer RS, Mousa SA, Böcker A, Pflücke D, et al. Transient opening of the perineurial barrier for analgesic drug delivery. Proc Natl Acad Sci U S A 2012; 109:E2018 - 27; http://dx.doi.org/10.1073/pnas.1120800109; PMID: 22733753
   PubMed Web of Science ®Google Scholar
• Lindmark T, Söderholm JD, Olaison G, Alván G, Ocklind G, Artursson P. Mechanism of absorption enhancement in humans after rectal administration of ampicillin in suppositories containing sodium caprate. Pharm Res 1997; 14:930 - 5; http://dx.doi.org/10.1023/A:1012112219578; PMID: 9244152
   PubMed Web of Science ®Google Scholar
• Leonard TW, Lynch J, McKenna MJ, Brayden DJ. Promoting absorption of drugs in humans using medium-chain fatty acid-based solid dosage forms: GIPET. Expert Opin Drug Deliv 2006; 3:685 - 92; http://dx.doi.org/10.1517/17425247.3.5.685; PMID: 16948563
   PubMedGoogle Scholar
• Tong HH, Du Z, Wang GN, Chan HM, Chang Q, Lai LC, et al. Spray freeze drying with polyvinylpyrrolidone and sodium caprate for improved dissolution and oral bioavailability of oleanolic acid, a BCS Class IV compound. Int J Pharm 2011; 404:148 - 58; http://dx.doi.org/10.1016/j.ijpharm.2010.11.027; PMID: 21094233
   PubMed Web of Science ®Google Scholar
• Maher S, Leonard TW, Jacobsen J, Brayden DJ. Safety and efficacy of sodium caprate in promoting oral drug absorption: from in vitro to the clinic. Adv Drug Deliv Rev 2009; 61:1427 - 49; http://dx.doi.org/10.1016/j.addr.2009.09.006; PMID: 19800376
   PubMed Web of Science ®Google Scholar
• Fan D, Wu X, Dong W, Sun W, Li J, Tang X. Enhancement by sodium caprate and sodium deoxycholate of the gastrointestinal absorption of berberine chloride in rats. Drug Dev Ind Pharm 2012; http://dx.doi.org/10.3109/03639045.2012.723219; PMID: 23020091
   PubMed Web of Science ®Google Scholar
• Lv XY, Li J, Zhang M, Wang CM, Fan Z, Wang CY, et al. Enhancement of sodium caprate on intestine absorption and antidiabetic action of berberine. AAPS PharmSciTech 2010; 11:372 - 82; http://dx.doi.org/10.1208/s12249-010-9386-z; PMID: 20237966
   PubMed Web of Science ®Google Scholar
• Ma Y, Zhang L, Zhao X, Shen Q. Analysis of daidzein in nanoparticles after oral co-administration with sodium caprate to rats by ultra-performance liquid chromatography-quadrupole-time-of-flight mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2012; 907:21 - 6; http://dx.doi.org/10.1016/j.jchromb.2012.08.026; PMID: 23010479
   PubMed Web of Science ®Google Scholar
• Raoof AA, Ramtoola Z, McKenna B, Yu RZ, Hardee G, Geary RS. Effect of sodium caprate on the intestinal absorption of two modified antisense oligonucleotides in pigs. Eur J Pharm Sci 2002; 17:131 - 8; http://dx.doi.org/10.1016/S0928-0987(02)00162-8; PMID: 12393140
   PubMed Web of Science ®Google Scholar
• Cianetti S, Cooper VB, Attenni B, Pucci V, Fiore F, Giuliano C, et al. Enhancement of intestinal absorption of 2-methyl cytidine prodrugs. Drug Deliv 2010; 17:214 - 22; http://dx.doi.org/10.3109/10717541003667814; PMID: 20233089
   PubMed Web of Science ®Google Scholar
• Ohnishi T, Aida K, Awazu S. Enhancement of blood-brain barrier permeability by sodium caprate. J Pharm Pharmacol 1999; 51:1015 - 8; http://dx.doi.org/10.1211/0022357991773483; PMID: 10528983
   PubMed Web of Science ®Google Scholar
• Preston E, Slinn J, Vinokourov I, Stanimirovic D. Graded reversible opening of the rat blood-brain barrier by intracarotid infusion of sodium caprate. J Neurosci Methods 2008; 168:443 - 9; http://dx.doi.org/10.1016/j.jneumeth.2007.11.004; PMID: 18155299
   PubMed Web of Science ®Google Scholar
• Brandhonneur N, Dollo G, Ratajczak-Enselme M, Deniau AL, Chevanne F, Estèbe JP, et al. Ex vivo and in vivo diffusion of ropivacaine through spinal meninges: influence of absorption enhancers. Int J Pharm 2011; 404:36 - 41; http://dx.doi.org/10.1016/j.ijpharm.2010.10.049; PMID: 21056096
   PubMed Web of Science ®Google Scholar
• Chao AC, Nguyen JV, Broughall M, Griffin A, Fix JA, Daddona PE. In vitro and in vivo evaluation of effects of sodium caprate on enteral peptide absorption and on mucosal morphology. Int J Pharm 1999; 191:15 - 24; http://dx.doi.org/10.1016/S0378-5173(99)00213-6; PMID: 10556736
   PubMed Web of Science ®Google Scholar
• Krug SM, Amasheh M, Dittmann I, Christoffel I, Fromm M, Amasheh S. Sodium caprate as an enhancer of macromolecule permeation across tricellular tight junctions of intestinal cells. Biomaterials 2013; 34:275 - 82; http://dx.doi.org/10.1016/j.biomaterials.2012.09.051; PMID: 23069717
   PubMed Web of Science ®Google Scholar
• Del Vecchio G, Tscheik C, Tenz K, Helms HC, Winkler L, Blasig R, et al. Sodium caprate transiently opens claudin-5-containing barriers at tight junctions of epithelial and endothelial cells. Mol Pharm 2012; 9:2523 - 33; http://dx.doi.org/10.1021/mp3001414; PMID: 22827574
   PubMed Web of Science ®Google Scholar
• Sugibayashi K, Onuki Y, Takayama K. Displacement of tight junction proteins from detergent-resistant membrane domains by treatment with sodium caprate. Eur J Pharm Sci 2009; 36:246 - 53; http://dx.doi.org/10.1016/j.ejps.2008.09.011; PMID: 19013238
   PubMed Web of Science ®Google Scholar
• Perera G, Barthelmes J, Vetter A, Krieg C, Uhlschmied C, Bonn GK, et al. Thiolated polycarbophil/glutathione: defining its potential as a permeation enhancer for oral drug administration in comparison to sodium caprate. Drug Deliv 2011; 18:415 - 23; http://dx.doi.org/10.3109/10717544.2011.570807; PMID: 21554106
   PubMed Web of Science ®Google Scholar
• Watson CJ, Rowland M, Warhurst G. Functional modeling of tight junctions in intestinal cell monolayers using polyethylene glycol oligomers. Am J Physiol Cell Physiol 2001; 281:C388 - 97; PMID: 11443038
   PubMed Web of Science ®Google Scholar
• Tomita M, Hayashi M, Awazu S. Absorption-enhancing mechanism of sodium caprate and decanoylcarnitine in Caco-2 cells. J Pharmacol Exp Ther 1995; 272:739 - 43; PMID: 7853188
   PubMed Web of Science ®Google Scholar
• Turner JR. ‘Putting the squeeze’ on the tight junction: understanding cytoskeletal regulation. Semin Cell Dev Biol 2000; 11:301 - 8; http://dx.doi.org/10.1006/scdb.2000.0180; PMID: 10966864
   PubMed Web of Science ®Google Scholar
• Feighery LM, Cochrane SW, Quinn T, Baird AW, O’Toole D, Owens SE, et al. Myosin light chain kinase inhibition: correction of increased intestinal epithelial permeability in vitro. Pharm Res 2008; 25:1377 - 86; http://dx.doi.org/10.1007/s11095-007-9527-6; PMID: 18163202
   PubMed Web of Science ®Google Scholar
• Anderberg EK, Lindmark T, Artursson P. Sodium caprate elicits dilatations in human intestinal tight junctions and enhances drug absorption by the paracellular route. Pharm Res 1993; 10:857 - 64; http://dx.doi.org/10.1023/A:1018909210879; PMID: 8321854
   PubMed Web of Science ®Google Scholar
• Sakai M, Imai T, Ohtake H, Azuma H, Otagiri M. Effects of absorption enhancers on cytoskeletal actin filaments in Caco-2 cell monolayers. Life Sci 1998; 63:45 - 54; http://dx.doi.org/10.1016/S0024-3205(98)00235-5; PMID: 9667764
   PubMed Web of Science ®Google Scholar
• Suzuki T, Hara H. Difructose anhydride III and sodium caprate activate paracellular transport via different intracellular events in Caco-2 cells. Life Sci 2006; 79:401 - 10; http://dx.doi.org/10.1016/j.lfs.2006.01.044; PMID: 16566947
   PubMed Web of Science ®Google Scholar
• Coyne CB, Ribeiro CM, Boucher RC, Johnson LG. Acute mechanism of medium chain fatty acid-induced enhancement of airway epithelial permeability. J Pharmacol Exp Ther 2003; 305:440 - 50; http://dx.doi.org/10.1124/jpet.102.047654; PMID: 12606647
   PubMed Web of Science ®Google Scholar
• Kurasawa M, Kuroda S, Kida N, Murata M, Oba A, Yamamoto T, et al. Regulation of tight junction permeability by sodium caprate in human keratinocytes and reconstructed epidermis. Biochem Biophys Res Commun 2009; 381:171 - 5; http://dx.doi.org/10.1016/j.bbrc.2009.02.005; PMID: 19338770
   PubMed Web of Science ®Google Scholar
• Krug SM, Amasheh S, Richter JF, Milatz S, Günzel D, Westphal JK, et al. Tricellulin forms a barrier to macromolecules in tricellular tight junctions without affecting ion permeability. Mol Biol Cell 2009; 20:3713 - 24; http://dx.doi.org/10.1091/mbc.E09-01-0080; PMID: 19535456
   PubMed Web of Science ®Google Scholar
• Wang X, Maher S, Brayden DJ. Restoration of rat colonic epithelium after in situ intestinal instillation of the absorption promoter, sodium caprate. Ther Deliv 2010; 1:75 - 82; http://dx.doi.org/10.4155/tde.10.5; PMID: 22816121
   PubMedGoogle Scholar
• Takatsuka S, Kitazawa T, Morita T, Horikiri Y, Yoshino H. Enhancement of intestinal absorption of poorly absorbed hydrophilic compounds by simultaneous use of mucolytic agent and non-ionic surfactant. Eur J Pharm Biopharm 2006; 62:52 - 8; http://dx.doi.org/10.1016/j.ejpb.2005.07.008; PMID: 16289777
   PubMed Web of Science ®Google Scholar
• Unger C, Eibl H, von Heyden HW, Krisch B, Nagel GA. [Blood-brain barrier and the penetration of cytostatic drugs]. Klin Wochenschr 1985; 63:565 - 71; http://dx.doi.org/10.1007/BF01733202; PMID: 2411995
   PubMedGoogle Scholar
• Erdlenbruch B, Jendrossek V, Eibl H, Lakomek M. Transient and controllable opening of the blood-brain barrier to cytostatic and antibiotic agents by alkylglycerols in rats. Exp Brain Res 2000; 135:417 - 22; http://dx.doi.org/10.1007/s002210000553; PMID: 11146820
   PubMed Web of Science ®Google Scholar
• Erdlenbruch B, Alipour M, Fricker G, Miller DS, Kugler W, Eibl H, et al. Alkylglycerol opening of the blood-brain barrier to small and large fluorescence markers in normal and C6 glioma-bearing rats and isolated rat brain capillaries. Br J Pharmacol 2003; b 140:1201 - 10; http://dx.doi.org/10.1038/sj.bjp.0705554; PMID: 14597599
   PubMed Web of Science ®Google Scholar
• Erdlenbruch B, Jendrossek V, Kugler W, Eibl H, Lakomek M. Increased delivery of erucylphosphocholine to C6 gliomas by chemical opening of the blood-brain barrier using intracarotid pentylglycerol in rats. Cancer Chemother Pharmacol 2002; 50:299 - 304; http://dx.doi.org/10.1007/s00280-002-0497-4; PMID: 12357304
   PubMed Web of Science ®Google Scholar
• Erdlenbruch B, Schinkhof C, Kugler W, Heinemann DE, Herms J, Eibl H, et al. Intracarotid administration of short-chain alkylglycerols for increased delivery of methotrexate to the rat brain. Br J Pharmacol 2003; a 139:685 - 94; http://dx.doi.org/10.1038/sj.bjp.0705302; PMID: 12812991
   PubMed Web of Science ®Google Scholar
• Everett RS, Vanhook MK, Barozzi N, Toth I, Johnson LG. Specific modulation of airway epithelial tight junctions by apical application of an occludin peptide. Mol Pharmacol 2006; 69:492 - 500; http://dx.doi.org/10.1124/mol.105.017251; PMID: 16288084
   PubMed Web of Science ®Google Scholar
• Chung NP, Mruk D, Mo MY, Lee WM, Cheng CY. A 22-amino acid synthetic peptide corresponding to the second extracellular loop of rat occludin perturbs the blood-testis barrier and disrupts spermatogenesis reversibly in vivo. Biol Reprod 2001; 65:1340 - 51; http://dx.doi.org/10.1095/biolreprod65.5.1340; PMID: 11673248
   PubMed Web of Science ®Google Scholar
• Wong CH, Mruk DD, Lee WM, Cheng CY. Targeted and reversible disruption of the blood-testis barrier by an FSH mutant-occludin peptide conjugate. FASEB J 2007; 21:438 - 48; http://dx.doi.org/10.1096/fj.05-4144com; PMID: 17167075
   PubMed Web of Science ®Google Scholar
• Mrsny RJ, Brown GT, Gerner-Smidt K, Buret AG, Meddings JB, Quan C, et al. A key claudin extracellular loop domain is critical for epithelial barrier integrity. Am J Pathol 2008; 172:905 - 15; http://dx.doi.org/10.2353/ajpath.2008.070698; PMID: 18349130
   PubMed Web of Science ®Google Scholar
• Zwanziger D, Hackel D, Staat C, Böcker A, Brack A, Beyermann M, et al. A peptidomimetic tight junction modulator to improve regional analgesia. Mol Pharm 2012; 9:1785 - 94; http://dx.doi.org/10.1021/mp3000937; PMID: 22524793
   PubMed Web of Science ®Google Scholar
• Winkler L, Gehring C, Wenzel A, Müller SL, Piehl C, Krause G, et al. Molecular determinants of the interaction between Clostridium perfringens enterotoxin fragments and claudin-3. J Biol Chem 2009; 284:18863 - 72; http://dx.doi.org/10.1074/jbc.M109.008623; PMID: 19429681
   PubMed Web of Science ®Google Scholar
• Veshnyakova A, Protze J, Rossa J, Blasig IE, Krause G, Piontek J. On the interaction of Clostridium perfringens enterotoxin with claudins. Toxins (Basel) 2010; 2:1336 - 56; http://dx.doi.org/10.3390/toxins2061336; PMID: 22069641
   PubMed Web of Science ®Google Scholar
• Veshnyakova A, Piontek J, Protze J, Waziri N, Heise I, Krause G. Mechanism of Clostridium perfringens enterotoxin interaction with claudin-3/-4 protein suggests structural modifications of the toxin to target specific claudins. J Biol Chem 2012; b 287:1698 - 708; http://dx.doi.org/10.1074/jbc.M111.312165; PMID: 22128179
   PubMed Web of Science ®Google Scholar
• Matsuhisa K, Kondoh M, Suzuki H, Yagi K. Comparison of mucosal absorption-enhancing activity between a claudin-3/-4 binder and a broadly specific claudin binder. Biochem Biophys Res Commun 2012; 423:229 - 33; http://dx.doi.org/10.1016/j.bbrc.2012.05.060; PMID: 22659740
   PubMed Web of Science ®Google Scholar
• Gao Z, Xu X, McClane B, Zeng Q, Litkouhi B, Welch WR, et al. C terminus of Clostridium perfringens enterotoxin downregulates CLDN4 and sensitizes ovarian cancer cells to Taxol and Carboplatin. Clin Cancer Res 2011; 17:1065 - 74; http://dx.doi.org/10.1158/1078-0432.CCR-10-1644; PMID: 21123456
   PubMed Web of Science ®Google Scholar
• Suzuki H, Kondoh M, Kakutani H, Yamane S, Uchida H, Hamakubo T, et al. The application of an alanine-substituted mutant of the C-terminal fragment of Clostridium perfringens enterotoxin as a mucosal vaccine in mice. Biomaterials 2012; 33:317 - 24; http://dx.doi.org/10.1016/j.biomaterials.2011.09.048; PMID: 21983135
   PubMed Web of Science ®Google Scholar
• Di Pierro M, Lu R, Uzzau S, Wang W, Margaretten K, Pazzani C, et al. Zonula occludens toxin structure-function analysis. Identification of the fragment biologically active on tight junctions and of the zonulin receptor binding domain. J Biol Chem 2001; 276:19160 - 5; http://dx.doi.org/10.1074/jbc.M009674200; PMID: 11278543
   PubMed Web of Science ®Google Scholar
• Goldblum SE, Rai U, Tripathi A, Thakar M, De Leo L, Di Toro N, et al. The active Zot domain (aa 288-293) increases ZO-1 and myosin 1C serine/threonine phosphorylation, alters interaction between ZO-1 and its binding partners, and induces tight junction disassembly through proteinase activated receptor 2 activation. FASEB J 2011; 25:144 - 58; http://dx.doi.org/10.1096/fj.10-158972; PMID: 20852064
   PubMed Web of Science ®Google Scholar
• Song KH, Fasano A, Eddington ND. Effect of the six-mer synthetic peptide (AT1002) fragment of zonula occludens toxin on the intestinal absorption of cyclosporin A. Int J Pharm 2008; 351:8 - 14; http://dx.doi.org/10.1016/j.ijpharm.2007.09.011; PMID: 17954018
   PubMed Web of Science ®Google Scholar
• Song KH, Eddington ND. The impact of AT1002 on the delivery of ritonavir in the presence of bioadhesive polymer, carrageenan. Arch Pharm Res 2012; a 35:937 - 43; http://dx.doi.org/10.1007/s12272-012-0520-1; PMID: 22644862
   PubMed Web of Science ®Google Scholar
• Song KH, Eddington ND. The influence of stabilizer and bioadhesive polymer on the permeation-enhancing effect of AT1002 in the nasal delivery of a paracellular marker. Arch Pharm Res 2012; b 35:359 - 66; http://dx.doi.org/10.1007/s12272-012-0217-5; PMID: 22370791
   PubMed Web of Science ®Google Scholar
• Song KH, Eddington ND. The influence of AT1002 on the nasal absorption of molecular weight markers and therapeutic agents when co-administered with bioadhesive polymers and an AT1002 antagonist, AT1001. J Pharm Pharmacol 2012; c 64:30 - 9; http://dx.doi.org/10.1111/j.2042-7158.2011.01381.x; PMID: 22150669
   PubMed Web of Science ®Google Scholar
• Li M, Oliver E, Kitchens KM, Vere J, Alkan SS, Tamiz AP. Structure-activity relationship studies of permeability modulating peptide AT-1002. Bioorg Med Chem Lett 2008; 18:4584 - 6; http://dx.doi.org/10.1016/j.bmcl.2008.07.028; PMID: 18667315
   PubMed Web of Science ®Google Scholar
• Masuda S, Oda Y, Sasaki H, Ikenouchi J, Higashi T, Akashi M, et al. LSR defines cell corners for tricellular tight junction formation in epithelial cells. J Cell Sci 2011; 124:548 - 55; http://dx.doi.org/10.1242/jcs.072058; PMID: 21245199
   PubMed Web of Science ®Google Scholar
• Yamamoto S, Nakase H, Matsuura M, Masuda S, Inui K, Chiba T. Tacrolimus therapy as an alternative to thiopurines for maintaining remission in patients with refractory ulcerative colitis. J Clin Gastroenterol 2011; 45:526 - 30; http://dx.doi.org/10.1097/MCG.0b013e318209cdc4; PMID: 21336140
   PubMed Web of Science ®Google Scholar
• Kluger MS, Clark PR, Tellides G, Gerke V, Pober JS. Claudin-5 controls intercellular barriers of human dermal microvascular but not human umbilical vein endothelial cells. Arterioscler Thromb Vasc Biol 2013; 33:489 - 500; http://dx.doi.org/10.1161/ATVBAHA.112.300893; PMID: 23288152
   PubMed Web of Science ®Google Scholar
• Van Itallie CM, Fanning AS, Bridges A, Anderson JM. ZO-1 stabilizes the tight junction solute barrier through coupling to the perijunctional cytoskeleton. Mol Biol Cell 2009; 20:3930 - 40; http://dx.doi.org/10.1091/mbc.E09-04-0320; PMID: 19605556
   PubMed Web of Science ®Google Scholar
• Yu AS, McCarthy KM, Francis SA, McCormack JM, Lai J, Rogers RA, et al. Knockdown of occludin expression leads to diverse phenotypic alterations in epithelial cells. Am J Physiol Cell Physiol 2005; 288:C1231 - 41; http://dx.doi.org/10.1152/ajpcell.00581.2004; PMID: 15689410
   PubMed Web of Science ®Google Scholar
• Hou J, Gomes AS, Paul DL, Goodenough DA. Study of claudin function by RNA interference. J Biol Chem 2006; 281:36117 - 23; http://dx.doi.org/10.1074/jbc.M608853200; PMID: 17018523
   PubMed Web of Science ®Google Scholar
• Campbell M, Hanrahan F, Gobbo OL, Kelly ME, Kiang AS, Humphries MM, et al. Targeted suppression of claudin-5 decreases cerebral oedema and improves cognitive outcome following traumatic brain injury. Nat Commun 2012; 3:849; http://dx.doi.org/10.1038/ncomms1852; PMID: 22617289
   PubMed Web of Science ®Google Scholar
• Kominsky SL. Claudins: emerging targets for cancer therapy. Expert Rev Mol Med 2006; 8:1 - 11; http://dx.doi.org/10.1017/S1462399406000056; PMID: 16887048
   PubMedGoogle Scholar
• Morin PJ. Claudin proteins in human cancer: promising new targets for diagnosis and therapy. Cancer Res 2005; 65:9603 - 6; http://dx.doi.org/10.1158/0008-5472.CAN-05-2782; PMID: 16266975
   PubMed Web of Science ®Google Scholar
• Kato-Nakano M, Suzuki M, Kawamoto S, Furuya A, Ohta S, Nakamura K, et al. Characterization and evaluation of the antitumour activity of a dual-targeting monoclonal antibody against claudin-3 and claudin-4. Anticancer Res 2010; 30:4555 - 62; PMID: 21115905
   PubMed Web of Science ®Google Scholar
• Suzuki M, Kato-Nakano M, Kawamoto S, Furuya A, Abe Y, Misaka H, et al. Therapeutic antitumor efficacy of monoclonal antibody against Claudin-4 for pancreatic and ovarian cancers. Cancer Sci 2009; 100:1623 - 30; http://dx.doi.org/10.1111/j.1349-7006.2009.01239.x; PMID: 19555390
   PubMed Web of Science ®Google Scholar
• Fofana I, Krieger SE, Grunert F, Glauben S, Xiao F, Fafi-Kremer S, et al. Monoclonal anti-claudin 1 antibodies prevent hepatitis C virus infection of primary human hepatocytes. Gastroenterology 2010; 139:953 - 64, e1-4; http://dx.doi.org/10.1053/j.gastro.2010.05.073; PMID: 20685314
   PubMed Web of Science ®Google Scholar
• Sharma P, Varma MV, Chawla HP, Panchagnula R. In situ and in vivo efficacy of peroral absorption enhancers in rats and correlation to in vitro mechanistic studies. Farmaco 2005; 60:874 - 83; http://dx.doi.org/10.1016/j.farmac.2005.08.007; PMID: 16243320
   PubMedGoogle Scholar